Moscow, Russia

Pavel Mikhailovich Yamanushkin


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,880 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pavel Mikhailovich Yamanushkin: Innovator in Antiviral Treatments

Introduction

Pavel Mikhailovich Yamanushkin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of antiviral treatments, particularly through his innovative research and development of novel compounds.

Latest Patents

Yamanushkin holds a patent for "Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases." This invention relates to new substituted 2-(5-hydroxy-2-methyl-1H-indol-3-yl)acetic acids, which serve as antiviral active ingredients. The patent outlines pharmaceutical compositions and methods for the prophylaxis and treatment of viral diseases, especially those caused by influenza viruses and hepatitis C (HCV) viruses. The compounds disclosed in the patent include various substituents that enhance their efficacy in treating these viral infections.

Career Highlights

Throughout his career, Yamanushkin has focused on developing antiviral medications that can significantly impact public health. His work has led to the creation of pharmaceutical compositions that are not only innovative but also practical for treating viral diseases.

Collaborations

Yamanushkin has collaborated with notable colleagues in his field, including Andrey Alexandrovich Ivashchenko and Nikolay Filippovich Savchuk. These collaborations have contributed to the advancement of research in antiviral treatments.

Conclusion

Pavel Mikhailovich Yamanushkin is a distinguished inventor whose work in antiviral treatments has the potential to improve health outcomes for many individuals. His innovative approach to developing new compounds showcases the importance of research in combating viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…